(Q53351375)

English

Pharmacokinetics of oseltamivir and oseltamivir carboxylate in critically ill patients receiving continuous venovenous hemodialysis and/or extracorporeal membrane oxygenation.

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

13 May 2018

http://europepmc.org/abstract/MED/23208833

Pharmacokinetics of oseltamivir and oseltamivir carboxylate in critically ill patients receiving continuous venovenous hemodialysis and/or extracorporeal membrane oxygenation. (English)

1 reference

Europe PubMed Central

PubMed publication ID

13 May 2018

http://europepmc.org/abstract/MED/23208833

extracorporeal membrane oxygenation

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

pharmacokinetics

1 reference

based on heuristic

inferred from title

Bruce A. Mueller

7

1 reference

Europe PubMed Central

PubMed publication ID

13 May 2018

http://europepmc.org/abstract/MED/23208833

author name string

Rachel F Eyler

1

1 reference

Europe PubMed Central

PubMed publication ID

13 May 2018

http://europepmc.org/abstract/MED/23208833

Michael Heung

2

1 reference

Europe PubMed Central

PubMed publication ID

13 May 2018

http://europepmc.org/abstract/MED/23208833

Melissa Pleva

3

1 reference

Europe PubMed Central

PubMed publication ID

13 May 2018

http://europepmc.org/abstract/MED/23208833

Kevin M Sowinski

4

1 reference

Europe PubMed Central

PubMed publication ID

13 May 2018

http://europepmc.org/abstract/MED/23208833

Pauline K Park

5

1 reference

Europe PubMed Central

PubMed publication ID

13 May 2018

http://europepmc.org/abstract/MED/23208833

Lena M Napolitano

6

1 reference

Europe PubMed Central

PubMed publication ID

13 May 2018

http://europepmc.org/abstract/MED/23208833

language of work or name

0 references

publication date

1 December 2012

1 reference

Europe PubMed Central

PubMed publication ID

13 May 2018

http://europepmc.org/abstract/MED/23208833

Pharmacotherapy

1 reference

Europe PubMed Central

PubMed publication ID

13 May 2018

http://europepmc.org/abstract/MED/23208833

32

1 reference

Europe PubMed Central

PubMed publication ID

13 May 2018

http://europepmc.org/abstract/MED/23208833

12

1 reference

Europe PubMed Central

PubMed publication ID

13 May 2018

http://europepmc.org/abstract/MED/23208833

1061-1069

1 reference

Europe PubMed Central

PubMed publication ID

13 May 2018

http://europepmc.org/abstract/MED/23208833

Hospitalized patients with 2009 H1N1 influenza in the United States, April-June 2009

1 reference

https://api.crossref.org/works/10.1002%2FPHAR.1151

21 January 2018

The use of antiviral agents for the management of severe influenza.

1 reference

https://api.crossref.org/works/10.1002%2FPHAR.1151

21 January 2018

Clinical pharmacokinetics of the prodrug oseltamivir and its active metabolite Ro 64-0802.

1 reference

https://api.crossref.org/works/10.1002%2FPHAR.1151

21 January 2018

Population pharmacokinetics of vancomycin in patients receiving extracorporeal membrane oxygenation

1 reference

https://api.crossref.org/works/10.1002%2FPHAR.1151

21 January 2018

Pharmacokinetics of caspofungin and voriconazole in critically ill patients during extracorporeal membrane oxygenation

1 reference

https://api.crossref.org/works/10.1002%2FPHAR.1151

21 January 2018

Determination of Oseltamivir Quality by Colorimetric and Liquid Chromatographic Methods

1 reference

https://api.crossref.org/works/10.1002%2FPHAR.1151

21 January 2018

Enteric absorption and pharmacokinetics of oseltamivir in critically ill patients with pandemic (H1N1) influenza.

1 reference

https://api.crossref.org/works/10.1002%2FPHAR.1151

21 January 2018

Daptomycin pharmacokinetics in critically ill patients receiving continuous venovenous hemodialysis

1 reference

https://api.crossref.org/works/10.1002%2FPHAR.1151

21 January 2018

Noncompartmental Determination of the Steady‐State Volume of Distribution

1 reference

https://api.crossref.org/works/10.1002%2FPHAR.1151

21 January 2018

Multiple-dose safety and pharmacokinetics of oral garenoxacin in healthy subjects

1 reference

https://api.crossref.org/works/10.1002%2FPHAR.1151

21 January 2018

Variability of antibiotic concentrations in critically ill patients receiving continuous renal replacement therapy: a multicentre pharmacokinetic study

1 reference

https://api.crossref.org/works/10.1002%2FPHAR.1151

21 January 2018

A preliminary study of atorvastatin plasma concentrations in critically ill patients with sepsis.

1 reference

https://api.crossref.org/works/10.1002%2FPHAR.1151

21 January 2018

Antibiotic dosing in critically ill patients with acute kidney injury

1 reference

https://api.crossref.org/works/10.1002%2FPHAR.1151

21 January 2018

Human carboxylesterases HCE1 and HCE2: ontogenic expression, inter-individual variability and differential hydrolysis of oseltamivir, aspirin, deltamethrin and permethrin

1 reference

https://api.crossref.org/works/10.1002%2FPHAR.1151

21 January 2018

Interleukin-6 alters the cellular responsiveness to clopidogrel, irinotecan, and oseltamivir by suppressing the expression of carboxylesterases HCE1 and HCE2.

1 reference

https://api.crossref.org/works/10.1002%2FPHAR.1151

21 January 2018

Anti-influenza prodrug oseltamivir is activated by carboxylesterase human carboxylesterase 1, and the activation is inhibited by antiplatelet agent clopidogrel.

1 reference

https://api.crossref.org/works/10.1002%2FPHAR.1151

21 January 2018

Identification of selected therapeutic agents as inhibitors of carboxylesterase 1: potential sources of metabolic drug interactions

1 reference

https://api.crossref.org/works/10.1002%2FPHAR.1151

21 January 2018

Structural insights into drug processing by human carboxylesterase 1: tamoxifen, mevastatin, and inhibition by benzil

1 reference

https://api.crossref.org/works/10.1002%2FPHAR.1151

21 January 2018

In Vitro Evaluation of Inhibitory Effects of Antidiabetic and Antihyperlipidemic Drugs on Human Carboxylesterase Activities

1 reference

https://api.crossref.org/works/10.1002%2FPHAR.1151

21 January 2018

Pharmacokinetics and tolerability of oseltamivir combined with probenecid.

1 reference

https://api.crossref.org/works/10.1002%2FPHAR.1151

21 January 2018

Similarity in pharmacokinetics of oseltamivir and oseltamivir carboxylate in Japanese and Caucasian subjects

1 reference

https://api.crossref.org/works/10.1002%2FPHAR.1151

21 January 2018

Plasma concentrations of oseltamivir and oseltamivir carboxylate in critically ill children on extracorporeal membrane oxygenation support

1 reference

https://api.crossref.org/works/10.1002%2FPHAR.1151

21 January 2018

Oseltamivir carboxylate accumulation in a patient treated by haemodiafiltration and extracorporeal membrane oxygenation.

1 reference

https://api.crossref.org/works/10.1002%2FPHAR.1151

21 January 2018

Pharmacokinetics of high-dose oseltamivir in healthy volunteers

1 reference

https://api.crossref.org/works/10.1002%2FPHAR.1151

21 January 2018

Identifiers

10.1002/PHAR.1151

1 reference

Europe PubMed Central

PubMed publication ID

13 May 2018

http://europepmc.org/abstract/MED/23208833

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

13 May 2018

http://europepmc.org/abstract/MED/23208833

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q53351375&oldid=2143578475"